NIAID's HIV/AIDS Research Program

Although progress has been made in the global fight against HIV/AIDS, the epidemic continues to devastate the United States and the international community with 56,300 new HIV infections each year in the U.S. and an estimated 33 million people living with HIV worldwide. As the leading U.S. government institute for HIV/AIDS research, NIAID is committed to conducting the research necessary to successfully end the fight against HIV/AIDS.

Through laboratories and clinics on the NIH campus in Bethesda, Md., and a vast network of supported research at universities, medical centers and clinical trial sites around the globe, NIAID is working to better understand HIV and how it causes disease, find new tools to prevent HIV infection including a preventive vaccine, develop new and more effective treatments for people infected with HIV, and hopefully, find a cure.

Behavioral Interventions

HIV prevention is not a one-size-fits all approach. To be successful, we must understand the sociocultural factors that contribute to HIV risk or protection, particularly among communities at greatest risk for HIV infection. NIAID is developing and testing behavioral interventions focused on men, women and adolescents at high risk for HIV infection and interventions geared toward people infected with HIV to reduce their risk of transmitting HIV to others. The strategies under investigation are multifaceted and include HIV counseling, testing for HIV and sexually transmitted diseases, substance abuse and mental health screenings, and referral for medical treatment and care.

You can leave a response, or trackback from your own site.